⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for photodynamic treatment

Every month we try and update this database with for photodynamic treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
DMSO-PDT of BCC - A 6 Year Follow upNCT00218829
Carcinoma, Basa...
18 Years - Norwegian University of Science and Technology
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorNCT02500550
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
ATIR101
Haploidentical ...
TBI regime
Non-TBI regime
18 Years - 65 YearsKiadis Pharma
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood CancerNCT02999854
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
ATIR101
Cyclophosphamid...
T-cell depleted...
T-cell replete ...
18 Years - 70 YearsKiadis Pharma
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorNCT02500550
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
ATIR101
Haploidentical ...
TBI regime
Non-TBI regime
18 Years - 65 YearsKiadis Pharma
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorNCT01794299
Acute Myeloid L...
Acute Lymphobla...
Myelodysplastic...
ATIR
18 Years - 65 YearsKiadis Pharma
DMSO-PDT of BCC - A 6 Year Follow upNCT00218829
Carcinoma, Basa...
18 Years - Norwegian University of Science and Technology
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: